Xbrane Biopharma AB (publ) (XBRANE)
Market Closed
15 Oct, 03:25 PM
XSTO 
kr
11. 20
-0.45
-3.8627%
kr
304.37M Market Cap
- P/E Ratio
- Div Yield
44,663 Volume
0 Eps
kr 11.65
Previous Close Want to track XBRANE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xbrane Biopharma AB (publ) (XBRANE) Statistics
Valuation metrics
Market Cap 304.37M
Enterprise value 184.05M
Trailing P/E (ttm) -5.82
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 2.04
Price/Book (mrq) 0.53
Enterprise Value/Revenue 2.21
Enterprise Value/EBITDA -3.04
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 86.99K
Average volume (90 days) 30.19K
Price summary
52-Week low 5.42
52-Week high 38.1
Beta -
50-Day moving average 10.62
200-Day moving average 10.04
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:125
Last split Date 17 Oct 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.9%
Operating margin -0.85%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.64
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.4
Total debt (mrq) -
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 3.19%
Book value per share (mrq) 26.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
